QIAGEN N.V. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount
QIAGEN N.V. (QGEN) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount of -$4.27 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-03-02.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2015-03-02
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount 12 month |
|---|---|
| 2014-12-31 | -$4.27M 20-F · filed 2015-03-02 |
| 2013-12-31 | -$2.21M 20-F · filed 2015-03-02 |
| 2012-12-31 | -$1.18M 20-F · filed 2015-03-02 |
| 2011-12-31 | -$714.00K 20-F · filed 2014-03-03 |